Evidence map›Paper›PMID 25645122›Full record

ArticleRespiratory research2015

Long term effects of an integrated care intervention on hospital utilization in patients with severe COPD: a single centre controlled study.

Elena Titova, Sigurd Steinshamn, Bent Indredavik, Anne Hildur Henriksen

Registry-linked trialAbstract readControlled Clinical Trial
In one paragraph

Article in Respiratory research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04119856 (Outgoing Lung Team - a Cross-sectorial and Preventive Intervention in Patients at Risk of Hospitalisation Due to Exacerbation of COPD), which is not on this map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04119856 nacompletednot on this mapstarted 2017, after this paper: background citation

Outgoing Lung Team - a Cross-sectorial and Preventive Intervention in Patients at Risk of Hospitalisation Due to Exacerbation of COPD

TypeinterventionalSponsorUniversity of AarhusRan2017 to 2020Enrolled144ConditionsCOPD, COPD ExacerbationArmsAffiliation with the outgoing lung team
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Impact of Integrated Care Model (ICM) on Direct Medical Costs in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD).Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  12. Article
  13. Impact of individualized care on readmissions after a hospitalization for acute exacerbation of COPD.International journal of chronic obstructive pulmonary disease · 2016
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elena TitovaDepartment of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, 7006, Norway. elena.titova@ntnu.no.
Sigurd SteinshamnDepartment of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, 7006, Norway. sigurd.steinshamn@ntnu.no.
Bent IndredavikDepartment of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, 7006, Norway. bent.indredavik@ntnu.no.
Anne Hildur HenriksenDepartment of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, 7006, Norway. anne.h.henriksen@ntnu.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledChronic obstructive pulmonary disease (COPD) is one of the main causes of morbidity and mortality globally. In Trondheim in 2008 an integrated care model (COPD-Home) consisting of an education program, self-management plan, home visits and a call centre for patient support and communication was developed. The objective was to determine the efficacy of an intervention according to the COPD-Home model in reducing hospital utilization among patients with COPD stage III and IV (GOLD 2007) discharged after hospitalization for acute exacerbations of COPD (AECOPD).

methodsA single centre, prospective, open, controlled clinical study comparing COPD-Home integrated care (IC) with usual care (UC).

resultsNinety-one versus 81 patients mean age 73.4 ± 9.3 years (57% women) were included in the IC group (ICG) and the UC group (UCG) respectively, and after 2 years 51 and 49 patients were available for control in the respective groups. During the year prior to study start there were 71 hospital admissions (HA) in the ICG and 84 in the UCG. There was a 12.6% reduction in HA in the ICG during the first year of follow-up and a 46.5% reduction during the second year (p = 0.01) compared to an 8.3% increase during the first year and no change during the second year in the ICG. During the year prior to study start, the number of hospital days (HD) was 468 in the ICG and 479 in the UCG. In the IC group, the number of HD was reduced by 48.3% during the first year (p = 0.01), and remained low during the second year of follow-up (p=0.02). In the UC group, the number of HD remained unchanged during the follow-up period. There was a trend towards a shorter survival time among patients in the ICG compared to the UCG, hazard ratio 1.33 [95% CI 0.77 to 2.33].

conclusionIntervention according to the COPD-Home model reduced hospital utilization in patients with COPD III and IV with a persisting effect throughout the 2 years of follow-up. However, there was a trend towards a shorter survival time in the intervention group.

Indexed as

Patient AdmissionAgedAged, 80 and overCase ManagementDelivery of Health Care, IntegratedFemaleHealth Knowledge, Attitudes, PracticeHealth ResourcesHome NursingHouse CallsHumansLength of StayMaleMiddle AgedNorwayPatient Care Team

Identifiers

PMID25645122
PMCPMC4335409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.